日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Integrated inference of cancer gene expression from cell-free plasma chromatin.

从无细胞血浆染色质中综合推断癌症基因表达。

Gulati Gunsagar S, Vasseur Damien, Nawfal Rashad, Sotudian Shahabeddin, Semaan Karl, Eid Marc, Seo Ji-Heui, Phillips Noa, Canniff John J, Savignano Hunter, Chhetri Surya B, Jin Zhenjie, Ou Yukun, Bani Mohamed-Amine, Mary Lee Gwo-Shu, Trowbridge Rachel, Epstein Ilana B, Rickards Gabriella, Cordeiro Paulo Roberto Da Silva, Zhang Ze, Chehade Razane El Hajj, James Brady, Massard Christophe, Italiano Antoine, Hollebecque Antoine, Soria Jean-Charles, André Fabrice, Badoual Cécile, Bellmunt Joaquim, Singh Harshabad, Aguirre Andrew J, Wolpin Brian M, Choueiri Toni K, Baca Sylvan C, Freedman Matthew L

Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients

低剂量肠道照射可提高转移性癌症患者PD-L1阻断疗法的疗效

Jianzhou Chen ,Antonin Levy ,Ai-Ling Tian ,Xuehan Huang ,Guoxin Cai ,Marine Fidelle ,Conrad Rauber ,Pierre Ly ,Eugénie Pizzato ,Lisa Sitterle ,Gianmarco Piccinno ,Peng Liu ,Sylvère Durand ,Misha Mao ,Liwei Zhao ,Valerio Iebba ,Hannah Felchle ,Anne-Laure Mallard de La Varende ,Julius Clemens Fischer ,Simon Thomas ,Tim F Greten ,Jennifer C Jones ,Cecilia Monge ,Sandra Demaria ,Silvia Formenti ,Lorenzo Belluomini ,Valeria Dionisi ,Christophe Massard ,Pierre Blanchard ,Charlotte Robert ,Clément Quevrin ,Eloise Lopes ,Céline Clémenson ,Michele Mondini ,Lydia Meziani ,Yizhou Zhan ,Chengbing Zeng ,Qingxin Cai ,Daphne Morel ,Roger Sun ,Pierre-Antoine Laurent ,Monica Mangoni ,Vanessa Di Cataldo ,Chiara Arilli ,Maike Trommer ,Simone Wegen ,Sebastian Neppl ,Rachel P Riechelmann ,Marcos P Camandaroba ,Elson Santos Neto ,Pierre-Edouard Fournier ,Nicola Segata ,Peter Holicek ,Lorenzo Galluzzi ,Aitziber Buqué ,Carolina Alves Costa Silva ,Lisa Derosa ,Guido Kroemer ,Chuangzhen Chen ,Laurence Zitvogel ,Eric Deutsch

Autocrine interferon poisoning mediates ADAR1-dependent synthetic lethality in BRCA1/2-mutant cancers

自分泌干扰素中毒介导 BRCA1/2 突变癌症中 ADAR1 依赖性合成致死

Roman M Chabanon ,Liudmila Shcherbakova ,Magali Lacroix-Triki ,Marine Aglave ,Jean Zeghondy ,Victor Kriaa ,Antoine Gougé ,Marlène Garrido ,Elodie Edmond ,Ludovic Bigot ,Dragomir B Krastev ,Rachel Brough ,Stephen J Pettitt ,Thibault Thomas-Bonafos ,Robert Samstein ,Christophe Massard ,Marc Deloger ,Andrew Nj Tutt ,Fabrice Barlesi ,Yohann Loriot ,Suzette Delaloge ,Marcel Tawk ,Cindy Degerny ,Yea-Lih Lin ,Barbara Pistilli ,Philippe Pasero ,Christopher J Lord ,Sophie Postel-Vinay

AZD8701, an Antisense Oligonucleotide Targeting FOXP3 mRNA, as Monotherapy and in Combination with Durvalumab: A Phase I Trial in Patients with Advanced Solid Tumors

AZD8701,一种靶向FOXP3 mRNA的反义寡核苷酸,作为单药疗法以及与度伐利尤单抗联合疗法:一项针对晚期实体瘤患者的I期试验

Siu, Lillian L; Postel-Vinay, Sophie; Villanueva-Vázquez, Rafael; de Velasco, Guillermo; Castanon Alvarez, Eduardo; Kyriakopoulos, Christos E; Johnson, Melissa; Ouali, Kaïssa; McMorn, Stephen; Angell, Helen K; Ng, Felicia; Saran, Shashank; Bayat, Mahdiye; Collins, Teresa; Roy, Archana; Lambert, Arthur W; Cho, Song; Miller, Neil; Petruzzelli, Michele; Stone, John; Massard, Christophe

Addressing screening failures in early-phase clinical trials in oncology: impact on patient outcomes and strategies for improvement

解决肿瘤早期临床试验中筛选失败的问题:对患者预后的影响及改进策略

Korakis, I; Ouali, K; Hanvic, B; Verlingue, L; Allignet, B; Lusque, A; Clementei, S; Magne, E; Massard, C; Delord, J-P; Cassier, P; Baldini, C; Segier, B; Gomez-Roca, C

From toxicity assessment to adaptive safety care: implementing comprehensive fast-track safety evaluation for anticancer drug development

从毒性评估到适应性安全护理:在抗癌药物研发中实施全面的快速安全评估

Champiat, S; Ouali, K; Laparra, A; Charalambous, A; Di Palma, M; Jordan, K; Massard, C; Aapro, M; Scotte, F

Real-world treatment patterns and effectiveness after disease progression on CDK4/6 inhibitors for HR-positive/HER2-negative metastatic breast cancer in the ESME-MBC cohort

ESME-MBC队列中HR阳性/HER2阴性转移性乳腺癌患者在接受CDK4/6抑制剂治疗后疾病进展的真实世界治疗模式和疗效

Varnier, R; Pérol, D; Jacot, W; Mailliez, A; Diéras, V; Dalenc, F; Gonçalves, A; Levy, C; Arnedos, M; Frenel, J-S; Bailleux, C; Massard, V; Brain, E; Sauterey, B; Savoye, A-M; Bosquet, L; Thery, J-C; Petit, T; Bachelot, T; Grinda, T; Ray-Coquard, I

Exploring KAT6 as a therapeutic target in breast cancer: epigenetic approaches for precision medicine

探索KAT6作为乳腺癌治疗靶点的可能性:精准医学的表观遗传学方法

Roussel-Simonin, Cyril; Fernandez-Martinez, Aranzazu; Postel-Vinay, Sophie; Mosele, Fernanda; Viansone, Alessandro; Massard, Christophe; Mouren, Adrien; Vibert, Julien; Pistilli, Barbara

Impact of Electronic Transition and Prefilled Templates on Drug Prescription Compliance: Retrospective Study

电子化转型和预填模板对药物处方依从性的影响:回顾性研究

Lambert, Aurélien; Hombourger, Benoit; Salleron, Julia; Chergui, Fadila; Vallance, Catherine; Nicolas, Nadège; Moussouni, Marie; Cherif, Lounisse; Chenot, Emile; Gavoille, Céline; Massard, Vincent

The future of androgen receptor targeting in prostate cancer: third-generation inhibitors and beyond

前列腺癌雄激素受体靶向治疗的未来:第三代抑制剂及后续疗法

Bernard-Tessier, Alice; Naoun, Natacha; Barraud, Solenn; Flippot, Ronan; Pobel, Cedric; Rey, Macarena; Baldini, Capucine; Massard, Christophe; Patrikidou, Anna; Fuerea, Alina; Di Palma, Mario; Albigès, Laurence; Loriot, Yohann; Fizazi, Karim